First, in COVID-19 patients, we observed increased BCR complementarity-determining region 3 (CDR3) lengths compared to sepsis (Figure S7D); such increases have been associated with antibody polyreactivity and autoimmunity (Meffre et al., 2001). Here, BCR is linked to COVID-19.